Philips: UBS raises target price, sees buy opportunity

(CercleFinance.com) - UBS has its target price for the Philips share to 48 euros from 42.
50 euros, after the Dutch health technology company reported its fourth-quarter results.

"We see Philips' disappointing fourth-quarter as a buying opportunity and continue to believe our investment thesis," the broker wrote in a note.

UBS said that it is maintaining its "conviction" for 2020, centred on growth in diagnosis and treatment (D&T), ongoing personal health (PH) recovery, and scope for margin expansion.

UBS reiterated its "buy" rating on the stock, which is currently up 0.3% at 43,3 euros on Euronext Amsterdam.

Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.